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Menadione licits low-level chemiluminescence (h >620 nm) associated with redox cycling of the quinone 
in mouse hepatic postmitochondrial fractions. This photoemission is suppressed when the animals are fed 
a diet containing the anticarcinogenic antioxidant, 2[3]-(tert-butyl)-4-hydroxyanisole (BHA), which leads 
to a 13-fold increase in NAD(P)H:quinone reductase (EC 1.6.99.2). Inhibition of the enzyme by 
dicoumarol completely abolishes the protective effect of BHA treatment and leads to higher 
chemiluminescence, reaching similar photoemission for BHA-treated and control animals. These findings 
indicate that the two-electron reduction promoted by quinone reductase prevents redox cycling and that 
BHA protects against reactive oxygen species by elevating the activity of this enzyme. 
Reactive oxygen species Dietary antioxidant DT-diaphorase Low-level chemiluminescence 
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1. INTRODUCTION 
Cytotoxic effects of quinones, including certain 
chemotherapeutic agents, have been related to the 
enzymatic or nonenzymatic formation of the cor- 
responding semiquinones in the cell and their 
subsequent reaction with molecular oxygen 
yielding superoxide anion radicals (Oi-) and 
regenerating the quinone, thus bringing about a 
redox cycling at the expense of cellular reducing 
equivalents (review [ 11). 
For isolated perfused rat liver it has been shown 
that redox cycling of menadione is accompanied by 
increased oxygen uptake, loss of cellular GSH and 
* To whom correspondence should be addressed 
increases in NADP+ and GSSG as well as increased 
low-level chemiluminescence in the red spectral 
region [2]. Similar results were reported for 
isolated hepatocytes with respect o 02 uptake [3], 
GSH level [3] and chemiluminescence [2]. 
The enzyme NAD(P)H : quinone reductase (EC 
1.6.99.2; also designated DT-diaphorase) is be- 
lieved to exert a protective function against such 
semiquinone redox cycling since it mediates obliga- 
tory two-electron reductions [4] to hydroquinones 
which can be detoxified by conjugation to yield the 
glucuronide and sulfate in preparation for elimina- 
tion from the cell ([5,6]; see also [2,3]). Inhibition 
of this enzyme by dicoumarol produced marked 
morphological effects in the form of blebbing of 
isolated hepatocytes supplemented with mena- 
dione [3] and was accompanied by an increase of 
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menadione-induced chemiluminescence in perfus- probably attributable to differences in the assay 
ed rat liver and isolated hepatocytes [2]. procedure and possibly the strain of mice. 
A dramatic increase of the NAD(P)H : quinone 
reductase specific activity in mouse liver cytosols 
occurs upon treatment of the animals with the an- 
ticarcinogenic antioxidant, 2[3]-(tert-butyl)-4-hy- 
droxyanisole (butylated hydroxyanisole; BHA) 
[7,8]. Thus, the question arises whether quinone 
toxicity can be lowered by BHA treatment. We 
present results of chemiluminescence measure- 
ments on mouse hepatic post-mitochondrial super- 
natant fractions supplemented with menadione, 
providing direct evidence for the protective effect 
of increased NAD(P)H : quinone reductase activity 
in BHA-treated mice. 
2.4. Chemiluminescence measurements 
2. MATERIALS AND METHODS 
2.1. Animal treatment 
Female NMRI mice, 5 weeks old, were fed a 
standard diet (Altromin) containing 7.5 g/kg BHA 
[7], and experiments were carried out at 8 weeks of 
age. 
Low-level chemiluminescence measurements 
were performed as in [9] using a photon-counter 
equipped with a red sensitive EM1 9658 
photomultiplier, maintained at -25°C by a ther- 
moelectric cooler. Photoemission is expressed in 
counts-s-‘. As the involvement of singlet 
molecular oxygen (dim01 emission at 634 and 
703 nm) in chemiluminescence during quinone 
redox cycling has been suggested [2], a 620 nm cut- 
off gelatin filter (Kodak) was placed between the 
cuvette and the light guide. Thus, light emission in 
the blue and green regions of the spectrum is not 
recorded in our experiments. Chemiluminescence 
was measured from S9 samples (1.5 mg protein per 
ml) in 0.1 M potassium phosphate buffer (pH 7.4) 
in a final volume of 6.5 ml. Samples were gassed 
with oxygen. NADPH (0.4 mM) and menadione 
(100 FM) were added through polyethylene tubing. 
2.5. Chemicals 
2.2. Preparation of the post-mitochondrial 
supernatant fraction 
After anaesthetizing the mice the livers were ex- 
cised, washed and homogenized with 4 vols ice- 
cold 0.25 M sucrose. Centrifugation of the 
homogenate for 20 min at 9000 x g provided the 
supernatant fractions (S9) which were used for en- 
zyme assays and chemiluminescence measure- 
ments .
BHA and dicoumarol were purchased from 
Sigma (Munchen) and menadione from Fluka 
(Buchs). Other chemicals or biochemicals were 
from E. Merck (Darmstadt) or Boehringer- 
Mannheim (Mannheim). 
Control BHA-Treated 
J---l __!_-__ 
2.3. Enzyme assay 
Determination of NAD(P)H : quinone reductase 
activity was performed as in [9]. The reaction mix- 
ture contained 0.2 mM NADH, 0.7 mg/ml bovine 
serum albumin and an appropriate amount of S9 
in 25 mM potassium phosphate buffer (pH 7.6) at 
25°C. The reaction was started by addition of 
menadione (final concentration, 60,~M) as elec- 
tron acceptor and was monitored at 340-400 nm 
using a dual-wavelength spectrophotometer 
(Model ZWS 11, Biochem. Co., Munchen). En- 
zyme specific activities presented in table 1 are con- 
siderably lower than those reported for CD- 1 mice 
[7,8] although a comparable degree of induction 
by BHA was observed. These discrepancies are 
I w 
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Fig. 1. Menadione-induced low-level chemiluminescence 
(> 620 nm) of post-mitochondrial supernatant fractions 
of mouse liver of controls and animals treated with 
BHA. Menadione (100~M) was added at the times 
indicated by the arrows. NADPH (0.4 mM) had been 
added 1 min prior to menadione. Protein content was 
1.5 mg/ml, dicoumarol 30,~M. 
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Table 1 
Effects of dietary BHA on menadione-induced low-level chemiluminescence and 
NAD(P)H : quinone reductase activities of mouse hepatic supernatant fractions 
Prior treatment Addition of Activities in post-mitochondrial supernatant fractions 
of mice 30pM 
dicoumarol NADH NAD(P)H : quinone Low-level 
oxidation reductase chemiluminescence 
(nmol.min-r. (nmol . min-’ . (counts. s-‘) 
mg-’ protein) mg-’ protein) 
Control diet 10.2 + 0.4 8.4 + 0.1 482 f 41 
Control diet + 1.8 k 0.8 648 + 72 
BHA diet 113.8 + 6.4 109.6 + 5.6 68 k 26 
BHA diet + 4.2 f 0.8 597 + 69 
The NAD(P)H : quinone reductase activity is defined as the dicoumarol-sensitive part of the 
total NADH oxidation rate. Chemiluminescence (>620 nm) was detected after addition of 
menadione (1OOgM) under conditions described in fig.1. Data are given as means k SE of 
3-4 experiments 
3. RESULTS 
Fig. 1 shows chemiluminescence traces of mouse 
post-mitochondrial supernatant (S9) fractions 
after addition of menadione (100/1M). NADPH 
was added 1 min prior to menadione and did not 
produce any light emission. NADPH was added to 
provide reducing equivalents for both the 
NADPH-cytochrome P-450 reductase (present as 
microsomal enzyme in the supernatant) and 
NAD(P)H : quinone reductase which is located 
mainly in the cytosol [5]. In controls, 1 min after 
starting the reaction with menadione, light emis- 
sion reached a maximum, followed by a slow 
decrease. In contrast, supernatant fractions from 
BHA-treated mice yielded a very small light signal 
upon addition of menadione. After inhibition of 
the NAD(P)H : quinone reductase by dicoumarol 
(fig. 1, lower) both the post-mitochondrial super- 
natant fractions of treated animals and controls 
exhibited increased chemiluminescence, reaching 
similar levels (fig. 1, table 1). 
Fig.2 indicates that, in the absence of 
dicoumarol, in hepatic supernatants of BHA- 
treated and control animals, the concentration of 
menadione has to exceed a certain level to yield a 
marked chemiluminescence increase, whereas in 
the controls chemiluminescence is already ob- 
served at concentrations somewhat higher than 
30pM. Thus, BHA treatment leads to a shift of 
sensitivity towards menadione by about one order 
of magnitude. Interestingly, this corresponds to 
the increase in enzyme activity by a factor of 13 
(table 1). Thus within a certain concentration 
April 1984 
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Fig.2. Protective effect of NAD(P)H : quinone reductase 
on the formation of light-emitting species during 
menadione redox cycling. Menadione at varying 
concentrations was added to hepatic post-mitochondrial 
supernatant fractions of BHA-treated animals ( q , n ) 
and controls (0, l ) in the absence (q , 0) and presence 
( n , l ) of dicoumarol. Conditions as described in fig. 1. 
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range (roughly between 50 and 250,~M) ;t clear 
protective effect by BHA treatment is observed 
whereas at 300,&3 menadione this protection ap- 
pears to be ~verw~e~rn~. At ah concentrations ex- 
amined, the presence of dicoumarof leads to higher 
chemiluminescence, and there is no significant dif- 
ference in the levels reached in BHA-treated or un- 
treated animats. 
Low-level chemiluminesccnce r flects the forma- 
tion of excited species uch as singlet molecular ox- 
ygen 181. C&r results provide further evidence for 
the a~~~rn~~~on that these excited species are 
generated during @none metaboism when one- 
electron reduction of the q&one is involved, but 
not during two-electron reduction. One-electron 
reduction results from microsomal NADPH- 
cytochrome P-450 reductase f43 and yields Oi- via 
reaction of rno~e~n~~ oxygen with the semi- 
quinone. Two-electron reduction yields the hydro- 
quinone which subsequently is a substrate for con- 
jugating enzymes such as ghrcuronyltransferases 
and sulfotransferases. Low-level chemilumines- 
cence as described here is thus interpreted as a con- 
sequence of NADPH~~~su~ng redox cycling, 
promoted by the NAD~H-c~ocbrom~ P-450 
reductase, yielding Oi- and excited species such as 
singlet oxygen. Consequently, an increased 
NAD(P)H : quinone reductase activity with con- 
comitant decrease of semiqu~none and Ui- forma- 
tion produced rn~ke~~ lowered photo~miss~on- 
Prior treatment with an antioxidant such as 
BHA has been shown to increase not only the 
NAD(P)H : quinone reductase but also CSH 
transferase and epoxide hydrolnse activities [9] and 
these enzymes may also be important in qdnone 
metabolism , However, the effect of dicoumarol as 
a specific inhibitor of the NAD(F)H : qumone 
reductase shows that the observed differences in 
chemiluminescence between post-mitochondrial 
supernatants of BHA-treated mice and controls 
are due to the NAD(P)H: quinone reductase, as 
they disappear in the presence of the inhib;tor 
(fig.1, table 1). The cytotoxicity of quinones, in- 
cluding therapeutic agents such as certain an- 
ticancer drugs, is beheved to be relaied to oxidative 
stress due to Oi- formation and subsequent reac- 
tions of this species. The results presented here 
support the pratective action of BHA treatment, 
and furthermore, indicate the practicability of 
ch~~Ium~nescenc~ measurements in monitoring 
eb~~es in qu~no~~ metabolism. 
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